HPV E7 oncogene expression impairs Rb function and confers CDK4/6 inhibitor resistance in cervical cancer. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does not ...
Adenocarcinoma of the cervix is a less common type of cervical cancer. It can cause symptoms such as vaginal bleeding. Treatment can include radiation therapy and surgery. Adenocarcinoma of the cervix ...
September 7, 2023—(BRONX, NY)—In findings with potentially important implications for cervical cancer screening, scientists at the National Cancer Institute (NCI)-designated Montefiore Einstein Cancer ...
Panel A shows worldwide age-standardized incidence and mortality rates for cervical cancer in 2022. Data are from the GLOBOCAN database and were collated by the International Agency for Research on ...
In a recent study published in the Journal of the National Cancer Institute, researchers assessed a novel human papillomavirus (HPV) and host deoxyribonucleic acid (DNA) methylation score for ...
Results from a phase 3 trial showing prolonged survival with the immunotherapy cemiplimab (Libtayo) in the second-line treatment of recurrent or metastatic cervical cancer are being hailed as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results